Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Patterson

Showing results (561-570 of 599) with videos related to

Pageof 60
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 3, 2016
Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of AmericaThomas F Patterson, George R Thompson, David W Denning, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 2, 2016
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of AmericaThomas F Patterson, George R Thompson, David W Denning, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 5, 2014
Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET)C A Kauffman, A G Freifeld, D R Andes, et al.
The Lancet. Infectious Diseases|December 17, 2020
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidancePhilipp Koehler, Matteo Bassetti, Arunaloke Chakrabarti, et al.
Frontiers in Immunology|March 27, 2023
Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiativeHector Bonilla, Michael J Peluso, Kathleen Rodgers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2006
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trialThomas J Walsh, Issam Raad, Thomas F Patterson, et al.
The New England Journal of Medicine|August 9, 2002
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosisRaoul Herbrecht, David W Denning, Thomas F Patterson, et al.
Journal of General Internal Medicine|January 13, 2025
Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult StudySuzanne D Vernon, Tianyu Zheng, Hyungrok Do, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2010
Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)Peter G Pappas, Barbara D Alexander, David R Andes, et al.
Annals of Internal Medicine|March 1, 1994
Didanosine compared with continuation of zidovudine in HIV-infected patients with signs of clinical deterioration while receiving zidovudine. A randomized, double-blind clinical trial. The Bristol-Myers Squibb AI454-010 Study GroupS L Spruance, A T Pavia, D Peterson, et al.
Pageof 60

Showing results (561-570 of 599) with videos related to

Sort By:
Pageof 60
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 3, 2016
Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of AmericaThomas F Patterson, George R Thompson, David W Denning, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 2, 2016
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of AmericaThomas F Patterson, George R Thompson, David W Denning, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|March 5, 2014
Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET)C A Kauffman, A G Freifeld, D R Andes, et al.
The Lancet. Infectious Diseases|December 17, 2020
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidancePhilipp Koehler, Matteo Bassetti, Arunaloke Chakrabarti, et al.
Frontiers in Immunology|March 27, 2023
Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiativeHector Bonilla, Michael J Peluso, Kathleen Rodgers, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 5, 2006
Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trialThomas J Walsh, Issam Raad, Thomas F Patterson, et al.
The New England Journal of Medicine|August 9, 2002
Voriconazole versus amphotericin B for primary therapy of invasive aspergillosisRaoul Herbrecht, David W Denning, Thomas F Patterson, et al.
Journal of General Internal Medicine|January 13, 2025
Incidence and Prevalence of Post-COVID-19 Myalgic Encephalomyelitis: A Report from the Observational RECOVER-Adult StudySuzanne D Vernon, Tianyu Zheng, Hyungrok Do, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2010
Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)Peter G Pappas, Barbara D Alexander, David R Andes, et al.
Annals of Internal Medicine|March 1, 1994
Didanosine compared with continuation of zidovudine in HIV-infected patients with signs of clinical deterioration while receiving zidovudine. A randomized, double-blind clinical trial. The Bristol-Myers Squibb AI454-010 Study GroupS L Spruance, A T Pavia, D Peterson, et al.
Pageof 60